Clinical trials
Phase 3 Lung Neoplasms trials in Portugal
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2006 | 1 |
| 2007 | 2 |
| 2013 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 4 |
| 2025 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Recruiting | 6 |
| Active, not recruiting | 4 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 3 |
| Genzyme, a Sanofi Company | 2 |
| Gustave Roussy, Cancer Campus, Grand Paris | 2 |
| Novartis Pharmaceuticals | 2 |
| Amgen | 1 |
| Boehringer Ingelheim | 1 |
| Eli Lilly and Company | 1 |
| Genmab | 1 |
| GlaxoSmithKline | 1 |
| Merck Sharp & Dohme LLC | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lung Neoplasms | 17 |
| Carcinoma, Non-Small-Cell Lung | 12 |
| Carcinoma | 3 |
| Lung Diseases | 3 |
| Neoplasms | 3 |
| Adenocarcinoma of Lung | 2 |
| Carcinoma, Bronchogenic | 2 |
| Neoplasms by Site | 2 |
| Respiratory Tract Diseases | 2 |
| Respiratory Tract Neoplasms | 2 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.